Abstract:BackgroundIn haemato-oncologic patients bacteremia is frequent increasing mortality rates, therefore surveillance and close follow up is essential to optimize treatment. The use of invasive devices used frequently in this population increases the incidence of infections by gram-positive microorganisms (currently gram-negative bacilli have been added). Therefore, we propose the characterization the microorganisms to identify the epidemiologic conditions, and the areas of improvement to establish improvement care strategies for this population.MethodsWe conducted a retrospective study at the haemato-oncologic diseases service at the National Medical Center "20 de Noviembre". Prevalence of bacteremia in pediatric patients with cancer and neutropenia in Mexican population, which ranges from 8% to 36%, assuming that our results could be similar to higher percentage, employing a proportion formula with a study population of 65 patients.ResultsIt was demonstrated in our population studied that in all cases of bacteremia, patients were in depth neutropenia at diagnosis. The most prevalence phase of chemotherapy was Induction phase (69.2%), with Total XV ST Jude protocol. The clinical data revealed the following frequencies in 100% of the patients: Fever (92%), Tachycardia (72%), Shivering and piloerection (65%), Elevated acute-phase reactants PCT (51%), CPR (32%), and Tachypnea (28%). Cases of Central Line-associated Bloodstream Infection (CLABSI) was reported in 86.2%, affecting individuals with vascular devices. The predominant microbiological isolate in our patients was Escherichia coli ESBL (31%), followed by Klebsiella pneumoniae (18%), and Pseudomonas aeruginosa (13.8%), Staphylococcus epidermidis (11%). Other bacteria were identified at even lower frequencies, such as Stenotrophomonas maltophilia (5%), Klebsiella oxytoca (5%), Staphylococcus aureus (3%), Serratia marcescens (3%), Enterococcus faecalis (3%), and Enterobacter cloacae (3%). The least observed in our population was the identification of Acinetobacter bauman nii (2%). The different outcomes recorded in our sample were highly consistent, with a resolution rate of infection in 97% of cases and 3% of cases resulting in death attributable to bacteremia (Table 1).ConclusionThe low mortality found in this study may be due to the early initiation of empirical antibiotic treatment in "golden hour", a protocol carried out in our Center, as well as the identification of severity scales.Table 1 General characteristics of children with bacteremia and malignant neoplasiaTotaln = 65 Neoplasm TypepHematologicaln = 48 Solidn = 17 Age, years8.13 ± 3.77.83 ± 3.79.00 ± 3.770.276Gender Female Male41 (63%)24 (37%)34 (71%)14 (29%)7 (41%)10 (69%)0.059Invasive Devices Without invasive devices Vascular catheter Urinary catheter Endotrachealtube Others2 (3%)63 (97%)9 (14%)8 (12%)1 (2%)2 (4%)46 (96%)8 (17%)5 (10%)1 (2%)017 (100%)2 (12%)2 (12%)00.96990.96990.928111 Depth Neutropenia Days65 (100%)9 (6 – 12)48 (100%)10 (6.5 - 11.5)17 (100%)7 (5.2 – 13.5)NA: 0.4931 * Microbiológical isolation Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosa S. Epidermidis S. Maltophilia Klebsiella oxytoca Staphyloccocus Aureus Serratia marcescens Enterococcus faecalis Enterobacter cloacae Staphyloccocus hominis Acinetobacter baumannii 21 (32%)12 (18%)9 (13.8%)7 (11%)3 (5%)3 (5%)2 (3%)2 (3%)2 (3%)2 (3%)1 (2%)1 (2%)18 (38%)10(21%)8 (17%)5 (10%)2 (4%)1 (2%)1 (2%)2 (4%)2 (4%)2 (4%)1 (2%)1 (2%)3 (18%)2 (12%)1 (6%)2 (12%)1 (6%)2 (12%)1 (2%)00000NAHospital stay (days)25(17.5 – 29.5)26(17.5 – 29.5)24(17.2 – 29.5)0.9107 * Outcome Infection resolved Attributable death63 (97%)2 (3%)46 (96%)2 (4%)17 (100%)00.9699

An emergent change in epidemiological and microbiological characteristics of bloodstream infections in adult patients experiencing febrile neutropenia resulting from chemotherapy for acute leukemia and lymphoma at reference centers in Chile, Ecuador, and Peru

Empirical polymyxin B therapy in febrile neutropenic patients with hematological diseases: A prospective, multicenter, observational clinical study

Clinical and epidemiological characterization of infections in pediatric hemato-oncology patients with febrile neutropenia in the North of Mexico

Association between inappropriate empirical antimicrobial therapy and mortality in gram-negative bloodstream infections in patients with febrile neutropenia and hematological malignancy

[Following-Up of Nosocomial Lower Respiratory Infection in Patients with Hematological Malignancy after Chemotherapy].

Clinical and Microbiological Characteristics of Febrile Neutropenia During Induction Chemotherapy in Adults With Acute Leukemia

Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009–2019)

Preneutropenic Fever in Patients With Hematological Malignancies: A Novel Target for Antimicrobial Stewardship

Etiological analysis of nosocomial infections in patients with acute leukemia and clinical treatment

Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis

Epidemiology of Febrile Neutropenia Episodes with Gram-Negative Bacteria Infection in Patients Who Have Undergone Chemotherapy for Hematologic Malignancies: A Retrospective Study of 10 Years’ Data from a Single Center

Infectious complications in adult acute myeloid leukemia: analysis of the Acute Leukemia French Association-9802 prospective multicenter clinical trial

Epidemiology of Bacteremia in Patients with Hematological Malignancies and Hematopoietic Stem Cell Transplantation and the Impact of Antibiotic Resistance on Mortality: Data from a Multicenter Study in Argentina

Epidemiological changes of invasive fungal disease in children with cancer: Prospective study of the National Child Program of Antineoplastic Drugs network, Chile

Risk of Mortality in Adult Cancer Febrile Neutropenia Patients with a Machine Learning Approach.

Bacteremias in Hemato-Oncological Pediatric Patients: Clinical and Microbiological Characteristics

Analysis of bacteremia at first-line antibiotic treatment for febrile neutropenia in children and adolescents: A retrospective, single-center analysis

Bloodstream infections in a Brazilian Pediatric Tertiary Oncology Hospital: 30-month analysis regarding the classification of the infection, distribution of microorganisms and their resistance profile

Early versus late onset bloodstream infection during neutropenia after high-dose chemotherapy for hematologic malignancy

Mortality in patients with hematological malignancies, febrile neutropenia, and septic shock

Pseudomonas Aeruginosa Bloodstream Infection in Patients with Hematological Diseases: Clinical Outcomes and Prediction Model of Multidrug-Resistant Infections